These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 16172792

  • 1. Quantitation of HDAC1 mRNA expression in invasive carcinoma of the breast*.
    Zhang Z, Yamashita H, Toyama T, Sugiura H, Ando Y, Mita K, Hamaguchi M, Hara Y, Kobayashi S, Iwase H.
    Breast Cancer Res Treat; 2005 Nov; 94(1):11-6. PubMed ID: 16172792
    [Abstract] [Full Text] [Related]

  • 2. ATBF1-a messenger RNA expression is correlated with better prognosis in breast cancer.
    Zhang Z, Yamashita H, Toyama T, Sugiura H, Ando Y, Mita K, Hamaguchi M, Kawaguchi M, Miura Y, Iwase H.
    Clin Cancer Res; 2005 Jan 01; 11(1):193-8. PubMed ID: 15671546
    [Abstract] [Full Text] [Related]

  • 3. HDAC6 expression is correlated with better survival in breast cancer.
    Zhang Z, Yamashita H, Toyama T, Sugiura H, Omoto Y, Ando Y, Mita K, Hamaguchi M, Hayashi S, Iwase H.
    Clin Cancer Res; 2004 Oct 15; 10(20):6962-8. PubMed ID: 15501975
    [Abstract] [Full Text] [Related]

  • 4. Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer.
    Zhang Z, Yamashita H, Toyama T, Yamamoto Y, Kawasoe T, Iwase H.
    Clin Cancer Res; 2006 Nov 01; 12(21):6410-4. PubMed ID: 17085653
    [Abstract] [Full Text] [Related]

  • 5. NCOR1 mRNA is an independent prognostic factor for breast cancer.
    Zhang Z, Yamashita H, Toyama T, Sugiura H, Ando Y, Mita K, Hamaguchi M, Hara Y, Kobayashi S, Iwase H.
    Cancer Lett; 2006 Jun 08; 237(1):123-9. PubMed ID: 16019133
    [Abstract] [Full Text] [Related]

  • 6. Estrogen-related receptor alpha and estrogen-related receptor gamma associate with unfavorable and favorable biomarkers, respectively, in human breast cancer.
    Ariazi EA, Clark GM, Mertz JE.
    Cancer Res; 2002 Nov 15; 62(22):6510-8. PubMed ID: 12438245
    [Abstract] [Full Text] [Related]

  • 7. Prognostic significance of insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5 expression in breast cancer.
    Mita K, Zhang Z, Ando Y, Toyama T, Hamaguchi M, Kobayashi S, Hayashi S, Fujii Y, Iwase H, Yamashita H.
    Jpn J Clin Oncol; 2007 Aug 15; 37(8):575-82. PubMed ID: 17675285
    [Abstract] [Full Text] [Related]

  • 8. High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis.
    Barbareschi M, Maisonneuve P, Aldovini D, Cangi MG, Pecciarini L, Angelo Mauri F, Veronese S, Caffo O, Lucenti A, Palma PD, Galligioni E, Doglioni C.
    Cancer; 2003 Aug 01; 98(3):474-83. PubMed ID: 12879463
    [Abstract] [Full Text] [Related]

  • 9. Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.
    Esteva FJ, Sahin AA, Cristofanilli M, Coombes K, Lee SJ, Baker J, Cronin M, Walker M, Watson D, Shak S, Hortobagyi GN.
    Clin Cancer Res; 2005 May 01; 11(9):3315-9. PubMed ID: 15867229
    [Abstract] [Full Text] [Related]

  • 10. High MMP-1 mRNA expression is a risk factor for disease-free and overall survivals in patients with invasive breast carcinoma.
    Cheng S, Tada M, Hida Y, Asano T, Kuramae T, Takemoto N, Hamada J, Miyamoto M, Hirano S, Kondo S, Moriuchi T.
    J Surg Res; 2008 May 01; 146(1):104-9. PubMed ID: 17663001
    [Abstract] [Full Text] [Related]

  • 11. Quantitative determination, by real-time reverse transcription polymerase chain reaction, of aromatase mRNA in invasive ductal carcinoma of the breast.
    Zhang Z, Yamashita H, Toyama T, Omoto Y, Sugiura H, Hara Y, Wu X, Kobayashi S, Iwase H.
    Breast Cancer Res; 2003 May 01; 5(6):R250-6. PubMed ID: 14580261
    [Abstract] [Full Text] [Related]

  • 12. Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen.
    Girault I, Lerebours F, Amarir S, Tozlu S, Tubiana-Hulin M, Lidereau R, Bièche I.
    Clin Cancer Res; 2003 Apr 01; 9(4):1259-66. PubMed ID: 12684393
    [Abstract] [Full Text] [Related]

  • 13. Histone deacetylase 1 mRNA expression in lung cancer.
    Sasaki H, Moriyama S, Nakashima Y, Kobayashi Y, Kiriyama M, Fukai I, Yamakawa Y, Fujii Y.
    Lung Cancer; 2004 Nov 01; 46(2):171-8. PubMed ID: 15474665
    [Abstract] [Full Text] [Related]

  • 14. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
    Maehle BO, Collett K, Tretli S, Akslen LA, Grotmol T.
    APMIS; 2009 Sep 01; 117(9):644-50. PubMed ID: 19703124
    [Abstract] [Full Text] [Related]

  • 15. WWOX--the FRA16D cancer gene: expression correlation with breast cancer progression and prognosis.
    Płuciennik E, Kusińska R, Potemski P, Kubiak R, Kordek R, Bednarek AK.
    Eur J Surg Oncol; 2006 Mar 01; 32(2):153-7. PubMed ID: 16360296
    [Abstract] [Full Text] [Related]

  • 16. Quantitative analysis of estrogen receptor-alpha and -beta messenger RNA expression in breast carcinoma by real-time polymerase chain reaction.
    Iwao K, Miyoshi Y, Egawa C, Ikeda N, Tsukamoto F, Noguchi S.
    Cancer; 2000 Oct 15; 89(8):1732-8. PubMed ID: 11042568
    [Abstract] [Full Text] [Related]

  • 17. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G, Kalogeras KT, Wirtz RM, Grimani I, Zografos G, Gogas H, Stropp U, Pectasides D, Skarlos D, Hennig G, Samantas E, Bafaloukos D, Papakostas P, Kalofonos HP, Pavlidis N, Fountzilas G.
    Breast Cancer Res Treat; 2009 Jul 15; 116(1):131-43. PubMed ID: 18668363
    [Abstract] [Full Text] [Related]

  • 18. Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer.
    Yang DC, Wang F, Elliott RL, Head JF.
    Anticancer Res; 2001 Jul 15; 21(1B):541-9. PubMed ID: 11299801
    [Abstract] [Full Text] [Related]

  • 19. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.
    Salhab M, Reed MJ, Al Sarakbi W, Jiang WG, Mokbel K.
    Breast Cancer Res Treat; 2006 Sep 15; 99(2):155-62. PubMed ID: 16541304
    [Abstract] [Full Text] [Related]

  • 20. Distinct mRNA, protein expression patterns and distribution of oestrogen receptors alpha and beta in human primary breast cancer: correlation with proliferation marker Ki-67 and clinicopathological factors.
    Jarzabek K, Koda M, Kozlowski L, Mittre H, Sulkowski S, Kottler ML, Wolczynski S.
    Eur J Cancer; 2005 Dec 15; 41(18):2924-34. PubMed ID: 16289616
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.